retatrutide clinical trial results 2024 2025 press release Lilly's triple agonist achieves 16.8% weight loss in phase 3 Targeting the weight within: obesity
Pay in 4 interest-free payments of $6.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24





























